Kunming Longjin Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 131.150 million compared to CNY 167.644 million a year ago. Operating income was CNY 3.542 million compared to CNY 12.343 million a year ago. Net income was CNY 1.340 million compared to CNY 10.922 million a year ago. Basic earnings per share from continuing operations was CNY 0.0033 compared to CNY 0.0273 a year ago.